๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase II study of Didemnin B in central nervous system tumors: A Southwest Oncology Group study

โœ Scribed by Sarah A. Taylor; Dorothy J. Giroux; Kurt A. Jaeckle; Timothy J. Panella; Shaker R. Dakhil; S. Clifford Schold

Book ID
110233760
Publisher
Springer US
Year
1998
Tongue
English
Weight
34 KB
Volume
16
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase II evaluation of bleomycin. A Sout
Phase II evaluation of bleomycin. A Southwest Oncology Group study
โœ Charles D. Haas; Charles A. Coltman Jr.; Jeffrey A. Gottlieb; Arthur Haut; James ๐Ÿ“‚ Article ๐Ÿ“… 1976 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 369 KB ๐Ÿ‘ 2 views

Bleomycin given intravenously (i.v.) or intramuscularly (i.m.) in twice-weekly doses of 10 mg/mz was evaluated for efficacy and toxicity in 382 patients. Responses were observed in 11/27 Hodgkin's diseases, 10/30 lymphomas, 9/22 squamous cell cancers of ectodermal origin, 12/26 germinal cancers, and

Phase II study of cisplatin in recurrent
Phase II study of cisplatin in recurrent astrocytomas in adults: A southwest oncology group study
โœ David J. Stewart; Robert M. O'Bryan; Muhyi Al-Sarraf; John J. Costanzi; Noboru O ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› Springer US ๐ŸŒ English โš– 215 KB

Thirty-one evaluable adults with recurrent astrocytomas were treated with Cisplatin 35 mg/m 2 I.V. daily for three days every 3 4 weeks. All patients had previously been irradiated and most had previously received chemotherapy. Approximately half had poor performance status. Two patients experienced